Continuation of selpercatinib beyond progression in RET fusion-positive NSCLC: Data from LIBRETTO-001 study Meeting Abstract
| Authors: | Drilon, A. E.; Chan, J.; Sands, J.; Tan, D. S. W.; Weiss, J.; Solomon, B.; Kim, Y. J.; Johnson, M. L.; Puri, T.; Sarno, M. A.; Kang, S.; Soldatenkova, V.; Duann, C. W.; Szymczak, S.; Subbiah, V.; Besse, B. |
| Abstract Title: | Continuation of selpercatinib beyond progression in RET fusion-positive NSCLC: Data from LIBRETTO-001 study |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S999 |
| Language: | English |
| ACCESSION: | WOS:000866211601248 |
| DOI: | 10.1016/j.annonc.2022.07.1108 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 980P -- Source: Wos |
